The strain A mouse has a high incidence of spontaneous lung tumors and is susceptible to lung tumor induction by chemical carcinogens. By utilizing transfection assay, Southern blot analysis, and DNA amplification techniques, we have detected an activated Ki-ras gene in the DNAs of both spontaneously occurring and chemically induced lung tumors of strain A mice. The point mutations in the spontaneous lung tumors were in both codon 12 (60%) and codon 61 (30%). In contrast, 100% of the mutations in the Ki-ras gene detected in methylnitrosourea-induced lung tumors and 93% of the mutations in the Ki-ras genes detected in benzo[ajpyreneinduced lung tumors were in codon 12, whereas 90% of the mutations in the Ki-ras genes detected in ethyl carbamateinduced lung tumors were in codon 61. The selectivity of mutations in the Ki-ras oncogene observed in chemically induced tumors, as compared to spontaneous tumors, suggests that these chemicals directly induce point mutations in the Ki-ras protooncogene. These data indicate that the strain A mouse lung tumor model is a very sensitive system to detect the ability of chemicals to activate the Ki-ras protooncogene in lung tissue.
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The strain A mouse lung tumor bioassay has been utilized for testing more than 300 compounds for carcinogenic activity (1) (2) (3) (4) . The strain A mouse also has a very high incidence of spontaneous lung tumors (nearly 100%o by 2 years of age), which is often a complicating factor in interpreting bioassay test results for carcinogenicity (1) (2) (3) (4) . The detection and characterization of activated oncogenes involved in the development of both spontaneously occurring and chemically induced lung tumors ofthe strain A mouse may offer one approach to define the mechanism(s) by which a chemical causes an increased incidence of lung tumors. Activated ras oncogenes have been detected in spontaneously occurring and chemically induced liver tumors of the B6C3F1 mouse (5) (6) (7) (8) and the pattern of activating mutations in these tumors has been compared. More than 60% of the activated oncogenes detected in furan-and furfural-associated liver tumors of the B6C3F1 mouse were different from those seen in spontaneous B6C3F1 mouse liver tumors. Activating mutations in the Ha-ras gene and several activated Ki-ras genes were detected in chemically induced mouse liver tumors, indicating that furan and furfural caused an increase in mouse liver tumors at least in part by a genotoxic mechanism (7). Likewise, Wiseman et al. (8) Transfection Assays. High molecular weight DNA was isolated from normal and tumor tissues and DNA transfection analysis was carried out by the protocol described (6) .
Southern Blot Analysis. This was performed as described (6) . High molecular weight DNA was isolated, digested with restriction enzymes, and separated by electrophoresis in a 0.7% agarose gel. The DNA was then transferred to a nitrocellulose sheet. The probe was a 0.618-kilobase Sst IIHincII fragment of the v-Ki-ras gene (Oncor, Gaithersburg, MD).
DNA Amplification. Amplification reactions were carried out essentially as described (11) . Briefly, a 100-1l reaction mixture containing 1 
RESULTS
Histology of Strain A Mouse Lung Tumors. The published criteria for diagnosis of lung tumors were followed (14) . Lung tumors in both spontaneously occurring and chemically treated mice were morphologically similar to those described (2) (3) (4) Table 1 (Table  1) . No foci were observed when NIH 3T3 cells were transfected with DNA isolated from 24-month-old and 12-month-old morphologically normal lung tissue from untreated and chemically treated strain A mice, respectively ( Table 1) .
Identification of Oncogenes in the Lung Tumors. Primary transfectant DNAs were analyzed by Southern blotting and hybridization with probes specific for Ki-ras by DNA transfection techniques. Fig. 2 All the p21 proteins of activated Ki-ras gene with a mutation in codon 61 migrated faster than the normal proteins, whereas the p21 proteins of activated Ki-ras gene with a mutation in codon 12 migrated slower relative to mouse endogenous p21 bands on SDS/polyacrylamide gels (data not shown). The correlation between the altered electrophoretic mobilities of the p21 proteins of the Ki-ras gene and the site of the mutations in the Ki-ras gene was similar to that observed (6) (7) (8) (17, 18) . Since activated Ki-ras genes were detected in all of the NIH 3T3 transformants derived from DNA from spontaneous tumors and B[a]P-and EC-induced tumor, MNU-induced lung tumor DNAs were directly analyzed for the presence of the G*C -) AFT transition at the second position of codon 12 Fig. 2h ). Both the normal allele and mutated allele of the Ki-ras gene were observed at the second position of codon 12. The intensity of the cytosine band (normal allele) was slightly stronger than the thymine band (mutated allele), which probably reflects the presence of some normal cells in the tumor tissue.
Some of the MNU-induced tumors were very small (<1 mm in diameter). Analysis of tumors by transfection assay was not possible. However, the PCR technique enabled us to analyze the specific mutations in the Ki-ras genes.
DISCUSSION
In the present study, we detected a high frequency of activated Ki-ras oncogenes in both spontaneously occurring and chemically induced lung tumors of strain A mice. An activated Ki-ras oncogene was found in 91% of spontaneous tumors, 87% of B tumor DNA showed that the mutated allele and normal allele were present in approximately equal amount, suggesting that the mutated allele was present in most of the tumor cells. These data suggest that the activated Ki-ras gene was present in the cell whose clonal expansion gave rise to the adenoma. We have shown that, in the development of chemically induced lung adenocarcinomas in the strain A mouse, some adenocarcinomas are developed from the progression of hyperplastic lesion to adenoma to adenocarcinomat arising within adenoma and then to adenocarcinoma (R.R.M., G.D.S., and M.W.A., unpublished data). Activated ras genes have been observed in several types of benign rodent tumors (6, 19, 20) as well as benign human colon tumors (21) . It is possible that the activation of the Ki-ras protooncogene is the initiation event. In any case, activation of the Ki-ras gene is one step in the development of strain A mouse lung tumors.
This study demonstrates ras protooncogene activation in B EC is carcinogenic in several rodent model systems. In this study, we have detected specific activation of Ki-ras protooncogenes in codon 61 by EC with 7 of 9 tumors having an A-T -* T-A transversion and 2 of 9 tumors having an AT --tCarcinoma arising within adenoma is characterized by focal areas of cytologic atypia, focal altered growth pattern, focal tinctorial differences, or a focal area (equivalent to more than three alveoli) where proliferating cell nuclei are crowded or piled up within a lesion that would otherwise be categorized as an adenoma.
Biochemistry: You et al. G-C transition. A very similar spectrum of mutations (11/14 tumors, A-T -* T-A transversions, and 2/14 tumors, APT --G-C transitions) were observed in the Ha-ras oncogene detected in hepatomas of male B6C3F1 mice treated with EC and vinyl carbamate, a potential metabolite of EC (8, 28) . Also, T. Bowden (personal communication) detected an activated Ha-ras protooncogene with an A-T -* TEA transversion at the second base of codon 61 in papillomas (5/5 tumors) and carcinomas (3/3 tumors) induced by EC in mouse skin. The A-T --T-A transversions and APT -G-C transitions are consistent with miscoding from deoxyadenosine adducts (29, 30) . However, the major DNA adduct formed from EC and vinyl carbamate is likely a 7-(2-oxoethyl)guanosine adduct rather than deoxyadenosine adducts (31) . Although it is clear that EC induced specific mutations in ras protooncogenes in several rodent tumor types, the mechanism(s) for the induction of these mutations by EC is unknown at present.
MNU is a very potent alkylating agent that preferentially modifies deoxyguanosine residues by methylating their N-7 and 06 positions (32) . As a consequence, modified deoxyguanosine residues may pair with thymidine instead of deoxycytosine, thus leading to the generation of G-C -+ APT transitions. This specific mutation has been consistently observed in mutagenesis studies in both the lac gene and gpt gene in E. coli (33, 34) and in Epstein-Barr virus shuttle vector in human cells (35) . Activated Ha-ras genes have been identified in the majority of rat mammary tumors induced with a single dose of MNU during sexual development (15, 16) . MNU activated the Ha-ras gene by a G-C --APT transition at the second position of codon 12 in 61 of 61 tumors harboring NIH 3T3-transforming DNA (15, 16) . In the present study, the same mutation, a G-C -+ A-T transition at the second position of codon 12, was observed in the Ki-ras gene in all (15/15) of the MNU-induced strain A mouse lung tumors examined. These observations indicated that the majority of the activating point mutations in the Ki-ras genes of MNU-, B[a]P-, and EC-induced lung tumors result from a direct genotoxic effect of these chemicals. The strain A mouse lung tumor model appears to be a very sensitive system for detecting the ability of chemicals to activate the Ki-ras protooncogene in lung tissue in vivo.
Activated Ki-ras protooncogenes have previously been detected in chemically induced rodent lung tumors and in human pulmonary adenocarcinomas. In tetranitromethaneinduced rat lung tumors, an activated Ki-ras gene with a G-C --A-T transition at the second position of codon 12 was observed in 19 of 20 tumors (20) . The same mutation in the Ki-ras gene was found in 10 of 10 tetranitromethane-induced B6C3F1 mouse lung tumors (20) . Rodenhuis et al. (36) and our laboratory (S. Reynolds and M.W.A., unpublished data) detected an activated Ki-ras gene in ':40% of human pulmonary adenocarcinomas examined. These data together with our present findings suggest that activation of the Ki-ras protooncogene is involved in the induction of pulmonary adenocarcinomas in both rodents and humans. The occurrence of a high percentage of activated Ki-ras genes in human pulmonary adenocarcinomas provides strong credibility to the strain A mouse as a model to study the development of this tumor type.
